Sartorius Stedim Biotech (SSB) announces that René Fáber, Chief Operating Officer and member of the Board of Directors, has been appointed Chief Executive Officer by its Board of Directors, effective March 28.

He will succeed Joachim Kreuzburg, who has been both Managing Director and Chairman of the Board since June 2007, and who will remain Chairman of the Board of SSB and Managing Director of its majority shareholder, the German Sartorius Group.

Appointed member of the Board of Directors in March 2019, René Fáber has been Deputy Managing Director of SSB since February 2022. In January 2019, he became a member of the Sartorius Management Board and took over the reins of its bioprocess solutions division.

In addition, SSB's shareholders at the Combined Annual General Meeting approved all resolutions by a large majority, including the proposal to pay a dividend of €1.44 per share for 2022.

Copyright (c) 2023 CercleFinance.com. All rights reserved.